Bioquell Inc, founded in 1925 and based in the United Kingdom, operates within the manufacturing sector, specifically focusing on test and measurement equipment. With a workforce of 201 to 500 employees, the company has generated significant revenue, reflecting its established presence in the industry. Bioquell's expertise is particularly highlighted in the area of bio-decontamination, as evidenced by its recent publication concerning compliance with the European Commission's Annex 1 guidelines for pharmaceutical companies. This document emphasizes the importance of automated room bio-decontamination using hydrogen peroxide vapor to ensure the safety, efficacy, and quality of sterile pharmaceutical products. It outlines the regulatory requirements for cleanroom disinfection, stressing the need for documented procedures to mitigate risks of organism resistance and the validation of disinfection methods. The publication also discusses the significance of continuous improvement in disinfection processes, particularly in critical facilities such as cleanrooms and HVAC systems. Overall, Bioquell Inc is positioned as a key player in providing solutions that align with stringent compliance standards in the pharmaceutical manufacturing sector.